Epsom, United Kingdom

Halina T Serafinowska

This inventor holds 1 USPTO granted patent. Top assignee: Beecham Plc. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Halina T Serafinowska. Retrieved from https://idiyas.com/inventor/halina-t-serafinowska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Halina T Serafinowska: Innovator in Antiviral Compounds

Introduction

Halina T Serafinowska is a distinguished inventor based in Epsom, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. Her innovative work has led to the creation of a patented compound that holds promise in the fight against viral infections.

Latest Patents

Halina holds a patent for "Antiviral phosphonylalkoxy purines," which is a compound of formula (I) or a pharmaceutically acceptable salt thereof. This compound is designed to combat viral infections effectively. The patent showcases her expertise and dedication to advancing medical science.

Career Highlights

Throughout her career, Halina has been associated with Beecham Plc, a prominent company in the pharmaceutical industry. Her role at Beecham has allowed her to collaborate with other talented professionals and contribute to groundbreaking research in antiviral therapies.

Collaborations

Halina has worked alongside notable colleagues, including Michael R Harnden and David M Duckworth. These collaborations have enriched her research and expanded the impact of her innovations in the pharmaceutical field.

Conclusion

Halina T Serafinowska's contributions to antiviral research exemplify her commitment to improving public health through innovation. Her patented work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…